Should we use sugammadex in rocuronium-induced anaphylaxis?
Croatian journal of anaesthesiology and intensive medicine · 26.12.2025 · 1 (1) · 52-59
DOI: 10.66166/cjaim.1.1.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Croatian journal of anaesthesiology and intensive medicine, online erschienen am 26.12.2025. Verfasst von Eleonora Goluža und 5 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Intraoperative anaphylaxis is a rare but potentially life-threatening complication of anaesthesia, with neuromuscular blocking drugs (NMBDs) being the most frequent cause. Published reports indicate that the incidence of anaphylaxis is higher for rocuronium compared to other non-depolarising NMBDs. Sugammadex is a novel reversal agent with a unique mechanism of action, specifically designed to encapsulate aminosteroid NMBDs and antagonise their pharmacological effects. Due to this mechanism, sugammadex has been suggested as a potential treatment option for rocuronium-induced anaphylaxis. Several case reports have described reversal or mitigation of rocuronium-induced anaphylaxis following sugammadex administration.In contrast, both in vitro and in vivo immunological studies suggest that sugammadex is unable to modify a type I hypersensitivity reaction. The small number of available case reports and limited prospective non-clinical immunological studies do not fully explain the underlying pathophysiological mechanisms. The role of sugammadex in rocuronium-induced anaphylaxis therefore remains unclear. Despite the reported clinical benefits, there are currently no recommendations to include sugammadex in standard anaphylaxis management algorithms.
Zitieren
APA
Goluža, E., Pranjić, M. N., Margaretić, N., Nenadić, S. Š., Erceg, A., & Uroda, K. (2025). Should we use sugammadex in rocuronium-induced anaphylaxis?. Croatian journal of anaesthesiology and intensive medicine, 1(1), 52-59. https://doi.org/10.66166/cjaim.1.1.6
Vancouver
Goluža E, Pranjić MN, Margaretić N, Nenadić SŠ, Erceg A, Uroda K. Should we use sugammadex in rocuronium-induced anaphylaxis?. Croatian journal of anaesthesiology and intensive medicine. 2025;1(1):52-59. doi:10.66166/cjaim.1.1.6
BibTeX
@article{Golua2025,
author = {Goluža, Eleonora and Pranjić, Marina Nakić and Margaretić, Nataša and Nenadić, Sandra Šprajc and Erceg, Ante and Uroda, Karlo},
title = {Should we use sugammadex in rocuronium-induced anaphylaxis?},
journal = {Croatian journal of anaesthesiology and intensive medicine},
year = {2025},
volume = {1},
number = {1},
pages = {52--59},
doi = {10.66166/cjaim.1.1.6}
}
EUVIMED